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Background: Orai1 is a plasma membrane protein that forms the pore of the calcium release activated calcium channel.
Humans with mutated Orai1 present with hereditary combined immunodeficiency, congenital myopathy and anhidrotic ecto-
dermal dysplasia. Consistent with the ectodermal dysplasia phenotype, enamel formation and mineralization is also abnormal
in Orai1 deficient patients. The expression pattern and potential functions of Orai1 in enamel formation remains unclear. To
contribute toward understanding the role of Orai1 in amelogenesis we characterized ORAI1 protein developmental pattern in
comparison with other ectodermal organs. We also examined the effects of Orai1 down-regulation in ameloblast cell prolifera-
tion and differentiation. Results: Our data show strong expression of ORAI1 protein during the ameloblast secretory stage,
which weans at the end of the maturation stage. In salivary glands, ORAI1 is expressed mainly in acini cells. ORAI1 expression
is also found in hair follicle and oral epithelium. Knockdown of Orai1 expression decreases cell proliferation and results in RNA
expression levels changes of key ameloblast genes regulating enamel thickness and mineralization. Conclusions: This study
provides insights in the anhidrotic ectodermal dysplasia phenotype due to Orai1 mutation and highlights the importance of
calcium signaling in controlling ameloblast differentiation and maturation during tooth development. Developmental Dynamics
244:1249–1258, 2015. VC 2015 Wiley Periodicals, Inc.
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Introduction
Calcium (Ca2þ) channels regulate many essential functions in
physiology including gene expression, immune cell function,
thrombus formation, muscle contractions, and bone turnover
(Fanger et al., 1995; Jackson et al., 2003; Schwarz et al., 2004;
Wada et al., 2006; Gwack et al., 2007). The lack of calcium chan-
nel activity results in disease states such as immunodeficiency
and developmental defects in mineralized tissues (Robinson et al.,
2012). Store operated calcium sensors in the endoplasmic reticu-
lum regulate Ca2þ concentrations in the lumen and directly con-
trol Ca2þ channels in the plasma membrane (Thompson et al.,
2009). Orai1 is an essential subunit of the Ca2þ release-activated
calcium (CRAC) channel. There is strong evidence that Orai1 is
the pore forming subunit of the CRAC channel and serves as a
selectivity filter (Prakriya et al., 2006; Yeromin et al., 2006).
When calcium levels in the endoplasmic reticulum are depleted,
Orai1 multimerizes and interacts with the stromal interacting
molecule (Stim1) to enhance calcium intake into the ER lumen
and to activate Ca2þ-dependent signal transduction (Thompson
et al., 2009). Over-activation of ORAI1 channels leads to large
Ca2þ currents into the ER. Two other proteins, ORAI2 and ORAI3,
are also present in mammalian cells. However, compared with
ORAI1, these two other ORAI proteins produce lower Ca2þ cur-
rents when paired with STIM1 (Mercer et al., 2006). It is unclear
whether the other ORAI proteins work in conjunction with ORAI1
in a heteromeric channel or they form independent channels in
specific cell types (DeHaven et al., 2007).
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S
Grant sponsor: American Association of Orthodontists Foundation
(AAOF); Grant number: N017774-00.
Drs. Zheng and Zinn contributed equally to this work.
*Correspondence to: Petros Papagerakis, Department of Orthodontics and
Pediatric Dentistry, Center for Computational Medicine and Bioinfor-
matics, Center for Organogenesis, University of Michigan, Ann Arbor, MI
48109. E-mail: petrosp@umich.edu
Article is online at: http://onlinelibrary.wiley.com/doi/10.1002/dvdy.
24307/abstract
VC 2015 Wiley Periodicals, Inc.
DEVELOPMENTAL DYNAMICS 244:1249–1258, 2015
DOI: 10.1002/DVDY.24307
1249
Based on recent studies, orai1 has been identified as a primary
contributor to the T-cell activation pathway (Feske et al., 2006;
McCarl et al., 2009; Thompson et al., 2009). It has also been high-
lighted in osteoclast differentiation and bone development (Robin-
son et al., 2012). In fact, mutated Orai1 causes human severe
combined immunodeficiency (SCID), a rare disorder that usually
results in death before age 1 due to severe infections (McCarl et al.,
2009). In these patients, defective orai1 inhibits T and B lympho-
cyte function. Two surviving patients with an orai1 mutation show
a defined list of symptoms including SCID, ectodermal dysplasia
with anhidrosis, global muscular hypotonia, and abnormal enamel
formation (McCarl et al., 2009). However, unlike how ectodermal
dysplasia normally presents, these patients do not display defects
in hair and nail formation. The deciduous and permanent denti-
tions of these patients have exposed dentin due to use-dependent
loss of the enamel layer. The observed defects in enamel fall into
the amelogenesis imperfecta (AI) family of diseases and the result-
ing enamel is soft and hypocalcified. The expression pattern and
potential roles of orai1 in enamel formation remain unclear.
Serving as the protective outer layer for teeth during masticatory
forces, enamel is the most mineralized tissue in the body. During
tooth formation, the ameloblasts form the enamel layer and sur-
round the entire surface. These cells are eventually lost as the tooth
emerges into the oral cavity (Nanci, 2007). The process of amelo-
blast differentiation and function is multifactorial and involves
many players. Ameloblasts go through three main stages of devel-
opment during enamel formation. The first is the inductive or prese-
cretory stage. During this period, the dentin is not yet mineralized
and there is a basal lamina between the inner enamel epithelium
and the dental papilla. Odontoblasts then send signals to the inner
enamel epithelium (IEE) to induce differentiation of these cuboidal
cells into columnar pre-ameloblasts. The second phase of develop-
ment is the secretory stage. The ameloblasts are now polarized
columnar cells that produce enamel proteins. These proteins form
the enamel matrix, which is then gradually mineralized with the
help of the alkaline phosphatase enzyme from the secretory to the
maturation stage. The secretory ameloblasts develop conical proc-
esses at the distal end called Tomes’ processes, which help to lay
down the prismatic layers of enamel. The enamel shape and thick-
ness is determined during the secretory stage of development
(Simmer et al., 2010). The final and longest stage of enamel forma-
tion is the maturational stage. This final process consists of thicken-
ing of the crystals laid down during the formative stage of
development and determines the hardness of the enamel layer
(Smith, 1998). The ameloblasts are reduced in height, the morphol-
ogy of their distal ends is altered, and they are still synthesizing
small amounts of matrix protein. During the transition from the
secretory to the maturation stage, and throughout maturation,
approximately 50% of the ameloblasts are lost due to programmed
cell death. The remaining ameloblasts become smooth ended cuboi-
dal cells that serve as a protective layer over the enamel before
eruption.
The columnar secretory ameloblasts are responsible for secretion
of essential enamel proteins such as enamelin, ameloblastin and
amelogenin into the enamel extracellular space, as well as the ini-
tial deposition of mineral. In addition, a major function of amelo-
blasts is Ca2þ transport into the extracellular space where it is
incorporated into calcium hydroxyl apatite crystals (Hubbard,
2000). It has been shown through chemical and radiographic stud-
ies of rat incisors that a large majority of total calcium is deposited
during the maturation stage of ameloblast development (Robinson
et al., 1974; Suga, 1982; Kawamoto and Shimizu, 1990; Smith,
1998). However, the mechanism for transport of Ca2þ from the
basal and out of the apical membrane of ameloblasts is still unde-
termined. The first of three theories suggests that the Ca2þ trans-
port occurs paracellularly, through intercellular junctions. The
second involves transport of Ca2þ transcellularly through the cyto-
plasm. The final theory focuses on transport through the ER of
ameloblasts (Smith, 1998; Hubbard, 2000). These theories for cal-
cium efflux into the mineralizing enamel remain to be verified.
Our study was initiated to test the hypothesis that Orai1 con-
trols ameloblast differentiation and function by targeting
calcium-dependent gene expression. First, we characterized
ORAI1 protein localization in the developing tooth bud of wild-
type (WT) mice. Second, we measured the potential effects of
Orai1 shRNA knockdown on cell proliferation and; and evaluate
the effects of Orai1 shRNA knockdown on ameloblast
differentiation-related gene expression. This is the first step in
understanding how defects in Orai1 may lead to changes in tooth
organogenesis. It will also provide insight on the cause of tooth
defects in diseases such as ectodermal dysplasia.
Results
ORAI1 and ORAI2 Protein Expression in Developing
Mouse Teeth, Salivary Glands, Hair Follicle, and Oral
Epithelium
Early embryonic stages of tooth development (E13 and E14)
show no ORAI1 or ORAI2 staining in any part of dental tissues.
ORAI1 expression becomes apparent in teeth during late embry-
onic (E17) tooth development (Fig. 1A, B) and continues in new-
born stage (NB) (Fig. 1C, D), postnatal day 4 (P4) (Fig. 1E, F) and
postnatal day 21 (P21) (Fig. 1G–I). In the embryonic tooth buds
(E17), ORAI1 is detected mainly in the internal enamel epithe-
lium but also sporadically in dental papilla and cervical loop
area (Fig. 1A, B). In NB mice ORAI1 staining is strong in prese-
cretory ameloblasts but also in stratum intermedium and young
odontoblasts (Fig. 1C, D). In P21 teeth, ORAI1 is detected in
secretory and maturation ameloblasts (Fig. 1G–I), and differenti-
ated odontoblasts (Fig. 1H). High magnification pictures show
clear cytoplasmic/membranous staining within the limits of light
microscopy. No significant signal is found when rabbit serum is
used instead of primary antibody in mouse teeth serial sections
(negative control) at any age as shown here for P21 (Fig. 1J). In
postnatal craniofacial tissues of P21 mice ORAI1 is also detected
in salivary glands (Fig. 1K), hair follicles (Fig. 1L) and oral epi-
thelial cells (Fig. 1F).
ORAI2 staining is first detected at E17 mainly expressed in the
IEE area and pre-ameloblastic cells (Fig. 2A, B). In teeth of new-
born (NB) mice ORAI2 is expressed strongly in differentiated
ameloblasts (Fig. 2C) and oral epithelial cells (Fig. 2D).
Orai1 Knockdown on Ameloblastic HAT-7 by shRNA
Orai1 knockdown (KD) in HAT-7 ameloblastic cells using the
shRNA lentiviral particles decreased Orai1 mRNA expression by
80% (Fig. 3A). Western blot analysis (Fig. 3B) followed by densi-
tometry measurement (Fig. 3C) using ImageJ software (NIH),
shows significant knockdown of ORAI1 at the protein level.
Scrambled shRNA is used as a control. We also examined by
immunofluorescence (IF) staining the levels of ORAI1 protein in
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scrambled shRNA transduced cells (control) and Orai1 shRNA
transduced HAT-7 cells. The IF data further confirm the specific-
ity of the ORAI1 antibody showing a clear down-regulation of
ORAI1 protein immunofluorescence staining in Orai1 shRNA
transduced cells compared with the control (Fig. 3D).
Effect of Orai1 Knockdown on HAT-7 Ameloblast Cell
Proliferation Rate
The proliferation of Orai1 shRNA knockdown cells compared
with control cells is assessed by MTT assay and cell count. The
MTT assay shows a significant decrease in proliferation rate
between the two groups (control cells cultured in normal medium
and orai1 shRNA knockdown cells). The greatest rate difference
occurs between days 2 and 4. Proliferation converged at day 7
when cell confluence reached 100%. Similar effects are observed
when using HAT-7 cells transduced with nonspecific shRNA len-
tivirus (scramble shRNA) and compared with Orai1 shRNA trans-
duced cells. Cell counting demonstrates a significant decrease in
proliferation rate in the Orai1 shRNA transduced cells compared
with the control cells transduced with nonspecific shRNA lentivi-
rus (Fig. 3E).
Effect of Orai1 Knockdown on Ameloblast Gene
Expression
The effects of Orai1 in ameloblasts are examined in two different
time points after virus transduction and selection. We collected
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S
Fig. 1. ORAI1 expression in the developing orofacial tissues. Immunohistochemistry (IHC) staining for ORAI1 was performed on tooth sections at
embryonic day E17 (A, B), newborn NB (C, D), postnatal P4 (E, F), and postnatal P21 (G–M). In E17, ORAI1 is mainly expressed in pre-
ameloblastic cells (A, B). In NB (C, D), P4 (E, F), and P21 (G–J), both ameloblasts and odontoblasts show positive staining of ORAI1 in molar (C–F,
J) and in the incisor root (G), middle (H), and tip (I) part. Replacement of the first antibody with rabbit serum results in lack of staining (J) serving
as negative control. ORAI1 also is detected on the cell membrane mucous acini in the salivary glands (K), skin epidermis (L), hair follicle (L, arrow)
and stratified squamous nonkeratinized epithelium (M). Arrows indicate the positive signal of IHC. Am, ameloblast; OD, odontoblast; MA, mucous
acini; Scale bars¼ 100 mm in A, E, K, L, M; 50 mm in B–D, F–J.
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RNA from postconfluent cells 4 weeks after the end of selection
(Fig. 4 A-H) and 2 weeks after the end of selection. Both data
show consistent trends of gene expression regulation. Orai1
down-regulation led to significant decreased expression of an
early ameloblast differentiation marker, i.e., dentin sialoprotein
(DSPP) (Fig. 4A) and two enamel matrix proteins, i.e., amelogenin
(Fig. 4B) and ameloblastin (Fig. 4C), both involved in enamel
secretion and control of the enamel thickness. Orai1 down-
regulation results also in down regulation of metallo-proteinase
20 (MMP20) RNA (Fig. 4D), another marker of secretory
ameloblasts.
Ameloblast differentiation and enamel maturation are directly
regulated by pH and ion transport (Lacruz et al., 2013). Among
the genes involved in ion transport in ameloblasts, cystic fibrosis
transmembrane conductance regulator (Cftr) and carbonic anhy-
drase 2 (Car2) are significantly up-regulated at the onset of the
maturation stage of amelogenesis when compared with the secre-
tory stage and are considered definitive markers of maturation
stage ameloblasts (Lacruz et al., 2013). To evaluate the potential
effects of Orai1 in maturation stage ameloblasts, we measured
the relative expression levels of calcium related genes, Car2,
plasma membrane calcium (Ca2þ) ATPase 1 (Pmca1) and Cftr.
Car2 is widely expressed in ameloblasts regulating the reversible
hydration of carbon dioxide into bicarbonate and protons (CO2þ
H2O () HCO3þHþ). Pmca1 is a transport protein that func-
tions to remove Ca2þ from the cell and is a known target of
Orai1 in other systems (Baryshnikov et al., 2009). Cftr is a protein
involved in the transport of chloride ions across cell membranes
and mice with Cftr mutation show a lack of calcium influx during
enamel maturation resulting in enamel hypomineralization (Sui
et al., 2003).
Both, Car2 and Pmca1 are found down-regulated in HAT-7
Orai1 knockdown cells (Fig. 4E, G) but only Pmca1 shows a stat-
istically significant down regulation (Fig. 4E). In contrast, Cftr
expression is up-regulated in HAT-7 orai1 knockdown cells (Fig.
4F).
To evaluate potential effects of Orai1 in ameloblast maturation
and mineralization, we also evaluated alkaline phosphatase
(ALP) levels, a marker of maturation ameloblasts, by reverse
transcriptase-polymerase chain reaction (RT-PCR) (Fig. 4H) and
by in situ staining (Fig. 4I). ALP RNA levels are found slightly
increased in Orai1 knockdown cells compared with control cells
but this difference is not statistically significant (Fig. 4H). The
alkaline phosphatase in situ staining is performed at 4 weeks of
cell culture. Compared with the control group without differentia-
tion media and the control group with differentiation media, the
Orai1 KD cells cultured with differentiation media show a slightly
stronger ALP staining. However, the difference between the con-
trol and KD plates is not significant (Fig. 4I).
Discussion
Orai1 is a transmembrane protein found in the plasma membrane
of many mammalian tissues and cell types. It is a four-domain
subunit that is part of the Ca2þ release activated Ca2þ (CRAC)
channels (Vig et al., 2006; Zhang et al., 2006; Putney, 2007).
Orai1 was first reported by Feske et al. through genome mapping
in a family with a form of immunodeficiency due to malfunction
of CRAC (Feske et al., 2006). Calcium depletion in the ER leads to
aggregation of the stim1 protein with orai1 and allows calcium
entry (Thompson et al., 2009). Recent studies have shown ORAI1-
deficient patients present with a form of anhidrotic ectodermal
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Fig. 2. ORAI2 expression in the developing orofacial tissues. Immunohistochemistry staining shows expression of ORAI2 in cervical loop and
pre-ameloblastic cells of molar (A, B) and ameloblastic cells of incisor (C) teeth at E17 (A, B) and NB (C). ORAI2 expression is also detected in
skin epidermis but not in hair follicle (D). Am, ameloblast; Scale bars¼ 100 mm in A, D; 50 mm in B, C.
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Fig. 3. Comparison between relative expression levels of Orai1 mRNA (A) and protein (B) expression levels in control cells (scramble shRNA,
“Mock”) and Orai1 knockdown cells. Densitometry analysis using the NIH ImageJ software (C), performed on the Western blot (B), shows a signifi-
cant decrease in ORAI1 protein expression in the knockdown cells. The representative data are presented as means6SD from at least three inde-
pendent replicates where data from cells transfected with Orai1 shRNA were compared with cells transfected with control virus (scramble shRNA).
Error bars indicate6 standard error. A Student’s t-test was used to determine statistical significance (**P< 0.01). A clear down-regulation of ORAI1
protein immunofluorescence staining is found in Orai1 shRNA transduced cells (ORAI1 KD) when compared with the control cells (D). HAT-7 cell
growth speed measured by cell counting demonstrates a significant proliferation decrease in the Orai1 shRNA transduced cells (Orai1 KD) when
compared with cells transduced with nonspecific shRNA lentivirus (control) (E).
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dysplasia, which includes characteristics of amelogenesis imper-
fect (McCarl et al., 2009). These patients also display severe
immune deficiency, myopathy and anhydrosis. Orai1-/- knock-
out mice were also generated and consistently displayed immu-
nodeficiency, overall smaller sizes and diminished enamel layer
in their teeth (Gwack et al., 2008, Robinson et al., 2012).
Although Orai1 is found to have almost ubiquitous expression in
many cell types, the symptoms of Orai1 deficiency involve spe-
cific mostly ectodermal derived organs. Much attention has been
devoted to finding the role of orai1in the development and func-
tion of these specific tissues. This study is aimed at exploring the
essential role of Orai1 in ameloblast differentiation and function.
Previous studies have shown that Orai1 is an important pore
subunit of the CRAC channels and may play a role in controlling
gene expression in cell differentiation (Zhou et al., 2011; Robin-
son et al., 2012). Our data show that ORAI1 protein (and OARI2
in less extend) is differentially expressed during odontogenesis
and strongly expressed mainly by postnatal ameloblasts and
odontoblasts suggesting a key role on the enamel and dentin
formation.
Despite this increase in interest in the CRAC system and Orai1,
it is still unclear what the downstream effectors are of the Orai1
gene expression. Although our data suggest that orai1 altered
expression can cause amelogenesis imperfecta by dysregulating
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Fig. 4. Orai1 regulates gene expression during ameloblast differentiation. Orai1 knocked-down (KD) by Orai1 shRNA transduction results in
changes in RNA levels of key ameloblast differentiation genes at postconfluent cells growing in mineralization medium for 4 weeks after selection.
In Orai1 KO cells Dspp (A), Amelogenin (B), Ameloblastin (C), metalloproteinase 20 (MMP20) (D), and plasma membrane calcium (Ca2þ) ATPase 1
(Pmca1) (E) showed a statistically significant down-regulation at the RNA levels. In contrast, cystic fibrosis transmembrane conductance regulator
(Cftr) (F) RNA levels were found up-regulated in Orai1 KO cells. Carbonic anhydrase 2 (Car2) (G) and alkaline phosphatase (Alp) (H) levels were not
significantly affected in Orai1 KD cells. Error bars indicate6 standard error. A Student’s t-test was used to determine statistical significance
(*P< 0.05). ALP in situ staining in HAT-7 cell shows no significant changes in color density in knockdown and control groups after culture with dif-
ferentiation medium (I).
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ameloblast gene expression, we do not know the exact genetic
pathways involved. In our system of Orai1 deletion, one possibil-
ity is that the NFAT pathway is dysregulated. NFAT pathway is
important in its regulation by the calcium/calmodulin-dependent
serine phosphatase calcineurin complex (Hogan et al., 2003).
Although this pathway has mainly been documented in associa-
tion with the immune response, this could be one of the missing
links in the control of gene expression by orai1 dependent cal-
cium entry in ameloblasts. NFAT is able to activate a large num-
ber of genes during the immune response as a result of a rise in
intracellular calcium levels. There is evidence that the NFAT
pathway is very versatile and is active in cell types other than
immune cells (Graef et al., 2003, Hill-Eubanks et al., 2003).
Although these studies were performed in muscle and nerve cells,
more work needs to be done in ameloblasts to show whether the
downstream effector of the Orai1/CRAC complex is indeed con-
nected to the NFAT pathway. NFAT pathway may be a compo-
nent of the proliferarion decrease observed in Orai1 shRNA
down-regulated HAT-7 cells. Of interest, despite the fact that the
knockdown only results in partial elimination of orai1 protein
from the HAT-7 cell line, we were able to see dramatic differences
in proliferation rate of ameloblasts. It is actually seems that orai1
is crucial in controlling the successful proliferation of HAT-7
cells. We used two techniques to quantitate the difference
between the proliferation of normal control HAT-7 cells and that
of the orai1 knockdown cell line. Using both the MTT assay and a
cell count comparison, we were able to see a significantly lower
proliferation rate in the Orai1 knockdown cells. Further studies
are needed to clarify the mechanisms by which Orai1 controls
cell proliferation.
We also show that Orai1 plays a potential key role in amelo-
blast differentiation and enamel maturation. The expression of
Orai1 during the ameloblast development may indicate a connec-
tion between calcium influx, gene expression and ameloblast dif-
ferentiation. By regulating ameloblast gene expression, such as
amelogenin and ameloblastin (this study), Orai1 may contribute
to the control of enamel thickness. Furthermore, by controlling
the expression of genes encoding calcium-signaling molecules
such as Pmca1 and in a less extend Car2 (this study), Orai1 goes
beyond the CRAC pathway to regulate calcium homeostasis and
enamel mineralization. Car2 and Pmca1 are both important in
the efflux of calcium out of the cell and into the enamel matrix,
(Zhang et al., 2006; Lacruz et al., 2013). Car2 is also important
for pH regulation. HCO3- neutralizes Hþ released during enamel
crystal formation, permitting continued crystal growth. Our data
also suggest that Orai1 may influence enamel maturation by reg-
ulating other ion channel expression such as CFTR (Bronckers
et al., 2010) and also by regulating the expression of enamel pro-
teinases such as Mmp20. Of interest, a recent study focused on
solute carrier family (Hill-Eubanks et al., 2003), member (Bergen-
dal, 2010) (SLC24A4) and ORAI1 (Wang et al., 2014). SLC24A4 is
a Naþ/Kþ/Ca2þ transporter that exchanges intracellular Ca2þ and
Kþ for extracellular Naþ. This study suggests that mutations in
SLC24A4 cause enamel malformations similar to those found in
ORAI1 deficient patients. They hypothesized that SLC24A4 is the
missing link that allows Ca2þ efflux out of the cell and into
the mineralizing enamel matrix. They also hypothesized that the
efflux of calcium through this channel lowers intracellular and
ER Ca2þ stores and activates the influx of Ca2þ through the prox-
imal membranes by means of the ORAI1/CRAC system. Taken
together, these findings and ours suggest that orai1 may play a
key role during both the secretory and the maturation stages of
enamel formation. Thus, calcium homeostasis may control the
expression of important enamel forming proteins and also regu-
late the amount of calcium secreted at the enamel matrix. This
potential role of Orai1 could explain the finding of amelogenesis
imperfecta in patients that have an ORAI1 deficiency.
The mechanism behind ameloblast differentiation and function
is still poorly understood. This study aims to contribute in uncov-
ering a critical role for the newly discovered protein orai1 in the
development, differentiation and function of ameloblasts.
Immuno-staining of embryonic mouse tooth sections (E13–E14)
showed that ORAI1 is not expressed in early embryonic dental
tissues but its expressions is initiated in later embryonic stage
E17 in inner enamel epithelium cells, the precursors of amelo-
blasts. The localization of orai1 in ameloblasts and odontoblasts
is first observed in the beginning of differentiation stages at new-
born (NB) mice. ORAI1 protein expression continues on enamel-
and dentin-forming cells throughout tooth development. Our
results suggest that ORAI1 is mainly active during the secretory
and maturational stages of ameloblast development and through-
out odontoblast differentiation. It is during the secretory and
maturational stages that ameloblasts produce the majority of the
enamel matrix proteins. Extracellular proteins form the enamel
matrix, which is then gradually mineralized from the secretory to
the maturation stage with the help of alkaline phosphatase
enzyme as well as by a complex network of ion channels. The
enamel shape and thickness is determined during the secretory
stage of development (Simmer et al., 2010). During the transition
from the secretory to the maturation stage, and throughout matu-
ration, approximately 50% of the ameloblasts are lost due to pro-
grammed cell death. The final maturational process consists of
thickening of the crystals laid down during the formative stage of
development and determines the hardness of the enamel layer
(Smith, 1998). It is clear that the expression of orai1 correlates
with the most important stages of ameloblast function and
enamel development. The precise roles of CRAC channels in tooth
organogenesis remain to be discovered. Future studies are still
required to determine the exact downstream effectors of orai1 in
controlling gene expression. Nevertheless, our results show for
the first time that Orai1 influences the expression of ameloblast
differentiation markers and should be considered an important
regulator of gene expression and matrix formation in enamel
formation.
Experimental Procedures
Animals
Animal use was approved by the Animal Welfare Committee of
the University of Michigan. Mouse heads from WT C57BL/6 mice
between E13 (cap stage of tooth development) and P21 were fixed
with formaldehyde, demineralized, embedded in paraffin, and
then sectioned. For immunohistochemistry, serial sections (7 mm
thick) of E13, E14, E17, NB, P4, and P21 mouse heads were used.
Immunohistochemistry
Mouse heads were sectioned at the incisor and molar tooth buds
and immune-stained for orai1 and orai2 protein localization
using rabbit anti-ORAI1 (1:250, ab59330, Abcam, Cambridge,
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MA) or rabbit anti-Orai2 (1:500, PA5-20369, Thermo Scientific,
Rockford, IL).
Primary antibodies were diluted with phosphate buffered saline
with 1% bovine serum albumin. Following washes with phos-
phate buffered saline (PBS)þ 1% bovine serum albumin (BSA),
the sections were incubated for 30 min with mouse anti-rabbit
IgG biotinylated secondary antibody. Secondary antibody was
followed by washes with PBSþ 1% BSA, then incubation with
an avidin-biotin-peroxidase complex. Visualization with 3-
30diaminobenzidine (DAB) was performed based on the peroxi-
dase substrate kit DAB (SK-4100, Vector Laboratories, Burlin-
game, CA) instructions, and the reaction was stopped before
detection of nonspecific staining in control preimmune serum-
treated sections. The histological staining was completed with a
hematoxylin counterstain. Sections were then mounted and pho-
tographed on an Olympus microscope. Serial sections where rab-
bit serum was used instead of primary antibody on E17- and
P21-old mouse teeth was used a control.
Cells
Sub-confluent cells were thawed and cultured in high glucose
DMEM supplemented with 100 units/ml penicillin G, 100 mg/ml
streptomycin (Invitrogen, Carlsbad, CA) and 10% (v/v) fetal
bovine serum (SAFC Biosciences, Lenexa, KS). Two sets of amelo-
blastic HAT-7 cells were grown in differentiation media for 10
days in the presence of pLKO.1-puro empty lentivirus (scramble
shRNA) and Orai1 shRNA lentiviral particles (viruses were pur-
chased as a kit through Sigma [#SHCLNV-NM_175423, MISSION
shRNA Lentiviral Transduction Particles]). One set of cells was
assayed for proliferation using an MTT assay. Another set of cells
was placed on 96-well plate (100 cells per well) and cultured in
DMEM/F12 medium for 8 days. Cell numbers were counted on
every day. Total RNA was collected from another set of cells cul-
tured in mineralization medium at two post confluent time points
(2 and 4 weeks after the end of the selection) and assayed for
mRNA expression of ameloblast differentiation markers using
quantitative real-time PCR (qRT-PCR).
Transduction
For transduction studies, HAT-7 cells were plated at 70% conflu-
ence in 6-well plates. After changing to serum-free DMEM/F-12
without antibiotics overnight, the control Lentivirus and Orai1
shRNA knockdown viruses were transducted into control and
knockdown HAT-7 cells, respectively, following Sigma Aldrich
Transduction protocol. A total of 8 mg/ml of hexadimethrine bro-
mide was added to improve the transduction efficiency. The Len-
tivirus particles were added using the desired multiplicity of
infection (MOI), which is the desired number of transducing par-
ticles per cell. The cells were then incubated for 24 hr before
selection was performed. After incubation, puromycin at a con-
centration of 1 mg/ml was used for selection of transduced cells.
The puromycin-containing medium was replaced every 3 days
until the resistant colonies were recognized.
qRT-PCR and RNA Expression
RNA was extracted from the HAT-7 cells using the QIAGEN
RNeasy system (QIAGEN; Izasa SA, Barcelona, Spain). Two
micrograms of total RNA from the control and knockdown sam-
ples were reverse transcribed with TaqMan reverse transcription
reagents (Applied Biosystems, Branchbury, NJ), following the
manufacturer’s recommendations. The resulting cDNA was then
amplified by RT-PCR or real time quantitative RT-PCR (qRT-PCR)
using AmpliTaq Gold DNA Polymerase (Applied Biosystems). The
RT-PCR products were subcloned into pGEM-T Easy vector
(Promega, Madison, WI) and confirmed by sequencing. For RNA
quantification, qRT-PCR amplifications were performed at 95C
for 30 sec, 60C for 30 sec, and 72C for 30 sec using specific pri-
mers for the ameloblast specific genes. The PCR primers are based
on the published cDNA sequences shown in Table 1. The relative
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TABLE 1. Primers Sequences for RT-PCR
Gene name 50- Sequence 30 Product size (bp) GenBank no.
b-actin Forward AAGTACCCCATTGAACACGG 257 NM_031144
Reverse ATCACAATGCCAGTGGTACG
Orai1 Forward GCTCTGCTGGGTGAAGTTCT 198 NM_001013982
Reverse AAGTGAACGGCAAAGACGAT
Amelogenin Forward TACCACCTCATCCTGGGAGC 164 U01245
Reverse CTGTTGAGACAGCACAGGGA
Ameloblastin Forward CAGAAGGCTCTCCACTGCAA 248 NM_012900
Reverse CCCCAAGGGTGTGGTAACAT
DSPP Forward GTGCTAAAGAACGCGAGGAC 200 NM_012790
Reverse GTCTCCATTCTGGCTCGTGT
MMP20 Forward CGACAATGCTGAGAAGTGGA 202 NM_001106800
Reverse GGGTCCATATAACGCTTGGA
PMCA1 Forward GGCGACTTTGGCATCACACT 120 NM_053311
Reverse TTTCAACTTGGTGCAAATTCCA
CFTR Forward TGTGGATGGGGGTTATGTGC 180 NM_031506
Reverse AGGACTACTGTGCAACCAGC
Car2 Forward AAGAGCAACGGACCAGAGAA 206 NM_019291
Reverse GCAAAGTCCTGGGAGTCATC
ALP Forward TGATCACTCCCACGTTTTCA 202 NM_013059
Reverse CTGGGCCTGGTAGTTGTTGT
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expression levels for each gene were calculated based on the
expression levels of beta-actin and the differences were presented
in graphs using the 2 DDCT method. P-values were calculated
using a two-sample t-test.
Proliferation Assays
An MTT assay was performed to quantify the differences in pro-
liferation rate between the cell lines. The MTT (4,5-dimethylthia-
zol-2-yl)2,5-diphenyltetrazolium bromide) assay is a
colorimetric assay that quantifies cell viability. The reaction
depends on tetrazolium dye reduction by NAD(P)H-dependent
oxidoreductase enzymes, which are active in the cytosolic com-
partment of the cell. One hundred microliters of 0.45 g/L MTT
solution was added to wells. Cells were incubated at 37C for 45–
60 min to allow color development and thereafter, 100 ml of 20%
sodium dodecyl sulfate (SDS) in dimethyl formamide H2O 1:1
solution was added to the wells. Plates were incubated overnight
at 37C to solubilize the formazan products. Absorbances were
measured at the wavelength of 570 nm. The levels of blue color
development in the control wells were designated as 100% viabil-
ity, and all further comparisons were based on that reference
level. Blank values, indicating the absorbance of MTT and 20%
SDS in DMF:H2O 1:1 solutions only, were subtracted from all
samples.
ALP Staining
For alkaline phosphatase (ALP) staining, transducted cells were
cultured in 6-well plates. The cells were incubated in DMEM with
or without AA and GP for 4 days. Thereafter, cells were fixed
with 10% formalin for 15 min, washed with PBS for three times,
and stained with NBT-BCIP (B5655, Sigma) for 30 min at 37
degree.
Western Blot Analysis
Cells are washed twice with PBS before being lysed for 20 min on
ice in RIPA lysis buffer. Total proteins (50 mg) per lane are sepa-
rated by SDS–polyacrylamide gel electrophoresis, and transferred
to a polyvinylidene difluoride membrane (Millipore, Billerica, MA).
The membrane is blocked with 5% nonfat milk, incubated over-
night at 4C with the primary antibody against ORAI1 (1:500).
Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body (1:2,500, Abcam, ab9485) is used to determine the loading
control. The membranes are incubated for 1 hr at room tempera-
ture with a horseradish peroxidase-conjugated anti-mouse or anti-
rabbit antibody, after washing. Bound antibodies are visualized by
enhanced chemiluminescence detection system. All bands are
measured by densitometry and normalized to GAPDH (mean-
s6 standard error of three or four experiments) using the ImageJ
software.
Immunocytofluorescence
HAT-7 cells are cultured on glass slides before fixation. After
blocking of no-specific antigens using 3% bovine serum albumin
(BSA), cells are incubated with rabbit anti-ORAI1 (1:250,
ab59330, Abcam, Cambridge, MA) for 1 hr at room temperature.
Next, a fluorescent Alexa Fluor 594 goat anti-rabbit (Invitrogen)
secondary antibody is applied to all sections followed by DAPI
(40,6-diamidine-2-phenylidole-dihydrochloride) counter staining.
Sections are then mounted with Prolong Gold antifade reagent
(Invitrogen). All sections are examined and then photographed
on an Olympus microscope. As negative controls, both omission
of primary antibody and omission of secondary antibodies are
used. Normal rabbit IgG instead of the primary antibody is also
used for determination of nonspecific binding of antibodies.
Statistics
We used a Student’s unpaired t-test for the statistical analysis of
our RT-PCR, MTT assay, and cell count data. Each experiment
was performed at least twice and the representative data are pre-
sented as means6 SD from at least three independent replicates.
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